Cravatex Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023
For the full year, sales was INR 5,036.59 million compared to INR 5,943.34 million a year ago. Revenue was INR 5,161.28 million compared to INR 6,042.66 million a year ago. Net income was INR 589.33 million compared to net loss of INR 198.87 million a year ago. Basic earnings per share from continuing operations was INR 228.05 compared to basic loss per share from continuing operations of INR 76.96 a year ago. Diluted earnings per share from continuing operations was INR 228.05 compared to diluted loss per share from continuing operations of INR 76.96 a year ago.